BB Seguridade Participações Second Quarter 2025 Earnings: Revenues In Line With Expectations
BB Seguridade Participações (BVMF:BBSE3) Second Quarter 2025 Results
Key Financial Results
- Net income: R$2.42b (up 13% from 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
BB Seguridade Participações Meets Expectations
Revenue was in line with analyst estimates.
Looking ahead, revenue is forecast to grow 1.3% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Insurance industry in Brazil.
Performance of the Brazilian Insurance industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
You should learn about the 2 warning signs we've spotted with BB Seguridade Participações (including 1 which is significant).
Valuation is complex, but we're here to simplify it.
Discover if BB Seguridade Participações might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BOVESPA:BBSE3
BB Seguridade Participações
Through its subsidiaries operates in the insurance, pension plans, and bonds, businesses in Brazil.
Flawless balance sheet and undervalued.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

Making sense of 1.75 trillion IPO
SpaceX? Only Fast in - Fast out!

INDIAN OIL CORPORATION IS THE TITAN IN TRANSITION
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
